Literature DB >> 32303463

Mechanisms of brain injury in newborn infants associated with the fetal inflammatory response syndrome.

Vivien Yap1, Jeffrey M Perlman2.   

Abstract

The fetal inflammatory response syndrome (FIRS) is characterized by umbilical cord inflammation and elevated fetal pro-inflammatory cytokines. Surviving neonates, especially very preterm infants, have increased rates of neonatal morbidity including neurodevelopmental impairment. The mechanism of brain injury in FIRS is complex and may involve "multiple hits." Exposure to in utero inflammation initiates a cascade of the fetal immune response, where pro-inflammatory cytokines can cause direct injury to oligodendrocytes and neurons. Activation of microglia results in further injury to vulnerable pre-myelinating oligodendrocytes and influences the integrity of the fetal and newborn's blood-brain barrier, resulting in further exposure of the brain to developmental insults. Newborns exposed to FIRS are frequently exposed to additional perinatal and postnatal insults that can result in further brain injury. Future directions should include evaluations for new therapeutic interventions aimed at reducing brain injury by dampening FIRS, inhibition of microglial activation, and regeneration of immature oligodendrocytes.
© 2020 Published by Elsevier Ltd.

Entities:  

Keywords:  Brain injury; Fetal inflammatory response syndrome; Microglia; Newborn infant; Oligodendrocytes

Mesh:

Substances:

Year:  2020        PMID: 32303463     DOI: 10.1016/j.siny.2020.101110

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  8 in total

Review 1.  Placental mediated mechanisms of perinatal brain injury: Evolving inflammation and exosomes.

Authors:  Alexander R Gall; Stephen Amoah; Yuma Kitase; Lauren L Jantzie
Journal:  Exp Neurol       Date:  2021-11-06       Impact factor: 5.330

Review 2.  White Matter Injury in Preterm Infants: Pathogenesis and Potential Therapy From the Aspect of the Gut-Brain Axis.

Authors:  Yu He; Yuni Zhang; Fang Li; Yuan Shi
Journal:  Front Neurosci       Date:  2022-04-29       Impact factor: 5.152

3.  Proteins Involved in Synaptic Plasticity Are Downregulated in the Cerebrospinal Fluid of Infants With Clinical Sepsis Complicated by Neuroinflammation.

Authors:  Ping-Ping Jiang; Shan-Shan Peng; Stanislava Pankratova; Ping Luo; Ping Zhou; You Chen
Journal:  Front Cell Neurosci       Date:  2022-05-11       Impact factor: 6.147

4.  Prenatal administration of multipotent adult progenitor cells modulates the systemic and cerebral immune response in an ovine model of chorioamnionitis.

Authors:  Luise Klein; Daan R M G Ophelders; Daniel van den Hove; Maurits Damoiseaux; Bart P F Rutten; Chris P M Reutelingsperger; Leon J Schurgers; Tim G A M Wolfs
Journal:  Brain Behav Immun Health       Date:  2022-05-02

Review 5.  The impact of trophic and immunomodulatory factors on oligodendrocyte maturation: Potential treatments for encephalopathy of prematurity.

Authors:  Josine E G Vaes; Myrna J V Brandt; Nikki Wanders; Manon J N L Benders; Caroline G M de Theije; Pierre Gressens; Cora H Nijboer
Journal:  Glia       Date:  2020-11-30       Impact factor: 7.452

Review 6.  Preventing Brain Injury in the Preterm Infant-Current Controversies and Potential Therapies.

Authors:  Nathanael Yates; Alistair J Gunn; Laura Bennet; Simerdeep K Dhillon; Joanne O Davidson
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

Review 7.  Impaired Oligodendrocyte Development Following Preterm Birth: Promoting GABAergic Action to Improve Outcomes.

Authors:  Julia C Shaw; Gabrielle K Crombie; Hannah K Palliser; Jonathan J Hirst
Journal:  Front Pediatr       Date:  2021-02-04       Impact factor: 3.418

Review 8.  Preterm Brain Injury, Antenatal Triggers, and Therapeutics: Timing Is Key.

Authors:  Daan R M G Ophelders; Ruth Gussenhoven; Luise Klein; Reint K Jellema; Rob J J Westerlaken; Matthias C Hütten; Jeroen Vermeulen; Guido Wassink; Alistair J Gunn; Tim G A M Wolfs
Journal:  Cells       Date:  2020-08-10       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.